Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Trial ID or NCT#



not recruiting iconNOT RECRUITING


To study the safety and feasibility of stereotactic radiation dose escalation following neoadjuvant chemotherapy with concurrent conventionally fractionated radiation, by evaluating the acute and late toxicity of treatment.

Official Title

Phase I Study of Dose Escalation Using Image-guided Radiotherapy to Deliver a Stereotactic Radiosurgical Boost After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Edward Graves
Jeffrey Norton, MD
Lei Xing
George A. Fisher Jr.
George A. Fisher Jr.
Medical oncologist, Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine
Teri A Longacre
Teri A Longacre
Pathologist, Surgical pathologist, Immunodiagnosis pathologist
Richard L. Kempson, MD, Professor in Surgical Pathology

Contact us to find out if this trial is right for you.


Laurie Ann Columbo